Read

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Who we are
Our solutions
Read, watch, listen
Pharmacy
Careers

Members
Client Resources
Pharmacy + Provider Resources
Drug Recalls
Events

Home
Read, watch, listen
Read

Explore what's trending at Prime

https://www.primetherapeutics.com/w/what-s-next-for-cell-and-gene-therapies Example Link

Specialty drugs

What’s next for cell and gene therapies

January 27, 2026

https://www.primetherapeutics.com/w/what-s-next-for-cell-and-gene-therapies

Stories

What’s next for cell and gene therapies

January 27, 2026

https://www.primetherapeutics.com/w/quarterly-drug-pipeline-january-2026 /quarterly-drug-pipeline-january-2026

Research & Publications

Quarterly Drug Pipeline: January 2026

January 27, 2026

https://www.primetherapeutics.com/w/quarterly-drug-approvals-january-2026 /quarterly-drug-approvals-january-2026

Research & Publications

Quarterly Drug Approvals: January 2026

January 26, 2026

The Latest

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/prime-therapeutics-appoints-public-affairs-veteran-katie-payne-as-chief-external-affairs-officer

Prime Therapeutics appoints public affairs veteran Katie Payne as chief external affairs officer

November 13, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-supports-fda-s-updated-biosimilar-recommendations

Prime Therapeutics supports FDA’s updated biosimilar recommendations

October 30, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-to-present-latest-managed-care-pharmacy-insights-at-amcp-nexus-2025

Prime Therapeutics to present latest managed care pharmacy insights at AMCP Nexus 2025

October 27, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-scales-judi-platform-implementations-with-support-from-pwc

Prime Therapeutics Scales Judi® Platform Implementations with Support from PwC

October 01, 2025

https://www.primetherapeutics.com/w/what-s-driving-medical-benefit-spend-prime-therapeutics-trend-report-shares-new-clues

What's driving medical benefit spend? Prime Therapeutics trend report shares new clues

September 04, 2025

https://www.primetherapeutics.com/w/prime-therapeutics-leading-research-shows-only-1-in-12-remain-on-a-glp-1-drug-for-obesity-at-three-years

Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

June 25, 2025

Showing 1 to 6 of 41

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/payers-play-an-evolving-role-in-small-cell-lung-cancer-treatment

Payers play an evolving role in small cell lung cancer treatment

December 23, 2025

https://www.primetherapeutics.com/w/inflammatory-bowel-disease-at-the-crossroads-of-medical-and-pharmacy

Inflammatory bowel disease at the crossroads of medical and pharmacy

November 25, 2025

https://www.primetherapeutics.com/w/end-of-year-outlook-what-s-next-for-drug-approvals-pipeline-and-innovation

End-of-year outlook: What’s next for drug approvals, pipeline, and innovation

November 10, 2025

https://www.primetherapeutics.com/w/integrated-oncology-insights-navigating-the-medical-and-pharmacy-claims-landscape

Integrated oncology insights: Navigating the medical and pharmacy claims landscape

October 23, 2025

https://www.primetherapeutics.com/w/how-to-safely-dispose-of-medications-on-national-drug-take-back-day

How to safely dispose of medications on National Drug Take Back Day

October 20, 2025

https://www.primetherapeutics.com/w/15-years-of-insight-prime-s-medical-pharmacy-trend-report-a-must-read-for-payers

15 years of insight: Prime’s Medical Pharmacy Trend Report — A must-read for payers

October 02, 2025

Showing 1 to 6 of 69

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/what-s-next-for-cell-and-gene-therapies

What’s next for cell and gene therapies

January 27, 2026

https://www.primetherapeutics.com/w/prime-careers-spotlight-january-2026 /prime-careers-spotlight-january-2026

Prime Careers Spotlight: January 2026

January 15, 2026

https://www.primetherapeutics.com/w/prime-s-creative-and-brand-work-receives-industry-recognition

Prime’s creative and brand work receives industry recognition

January 12, 2026

https://www.primetherapeutics.com/w/oncology-pharmacists-are-essential-in-precision-medicine-says-prime-therapeutics-expert

Oncology pharmacists are essential in precision medicine, says Prime Therapeutics expert

January 05, 2026

https://www.primetherapeutics.com/w/prime-therapeutics-supports-nonprofit-s-efforts-to-empower-people-with-disabilities-to-live-life-to-the-fullest

Prime Therapeutics supports nonprofit’s efforts to empower people with disabilities to live life to the fullest

December 29, 2026

https://www.primetherapeutics.com/w/prime-therapeutics-information-technology-team-earns-top-industry-honors

Prime Therapeutics information technology team earns top industry honors

December 22, 2025

Showing 1 to 6 of 169

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/prime-presents-at-73rd-annual-roy-a-bowers-pharmaceutical-conference-on-nov-11

Prime presents at 73rd annual Roy A. Bowers Pharmaceutical Conference on Nov. 11

October 29, 2025

https://www.primetherapeutics.com/w/prime-presents-at-hlth-usa-conference-on-oct-20

Prime presents at HLTH USA conference on Oct. 20

October 17, 2025

https://www.primetherapeutics.com/w/prime-presents-2025-medical-pharmacy-trend-report-webcast-on-oct-13

Prime presents 2025 Medical Pharmacy Trend Report webcast on Oct. 13

September 23, 2025

https://www.primetherapeutics.com/w/prime-expert-presents-at-the-most-favored-nation-mandate-webinar

Prime expert presents at “The Most Favored Nation Mandate” webinar on Sept. 10

September 02, 2025

https://www.primetherapeutics.com/w/prime-presents-at-national-association-of-specialty-pharmacy-nasp-annual-meeting-from-sept-14-17

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

August 25, 2025

https://www.primetherapeutics.com/w/prime-presents-at-isg-digital-business-summit-on-nov-14

Prime presents at ISG Digital Business Summit on Nov. 14

November 05, 2024

Showing 1 to 6 of 37

Categories

PA Sub-Categories

https://www.primetherapeutics.com/w/managed-healthcare-executive-why-timing-access-and-interpretation-matter-in-oncology-biomarker-testing https://www.managedhealthcareexecutive.com/view/why-timing-access-and-interpretation-matter-in-oncology-biomarker-testing

Managed Healthcare Executive: Why Timing, Access and Interpretation Matter in Oncology Biomarker Testing

January 20, 2026

https://www.primetherapeutics.com/w/forbes-causes-and-implications-of-discontinuing-glp-1-weight-loss-drugs https://www.forbes.com/sites/joshuacohen/2026/01/12/causes-and-implications-of-discontinuing-glp-1-weight-loss-drugs/

Forbes: Causes And Implications Of Discontinuing GLP-1 Weight Loss Drugs

January 12, 2026

https://www.primetherapeutics.com/w/managed-healthcare-executive-predictions-for-2026-from-marci-chodroff-m.d.-jeffrey-casberg-rph-m.s.-and-others https://www.managedhealthcareexecutive.com/view/predictions-for-2026-marci-chodroff-m-d-jeffrey-casberg-rph-m-s-and-others

Managed Healthcare Executive: Predictions for 2026 from Marci Chodroff, M.D., Jeffrey Casberg, RPh, M.S., and others

January 02, 2026

https://www.primetherapeutics.com/w/harper-s-bazaar-arabia-weight-loss-wonder-drugs-are-we-now-seeing-their-wider-impact- https://www.harpersbazaararabia.com/hbanews/weight-loss-wonder-drugs-are-we-now-seeing-their-wider-impact

Harper's Bazaar Arabia: Weight Loss Wonder Drugs: Are We Now Seeing Their Wider Impact?

January 02, 2026

https://www.primetherapeutics.com/w/managed-healthcare-executive-predictions-for-2026-from-margaret-a.-murray-m.p.a.-eric-hunter-mba-shawn-gremminger-m.p.p.-and-others https://www.managedhealthcareexecutive.com/view/predictions-for-2026-from-margaret-a-murray-m-p-a-eric-hunter-mba-shawn-gremminger-m-p-p-and-others

Managed Healthcare Executive: Predictions for 2026 from Margaret A. Murray, M.P.A., Eric Hunter, MBA, Shawn Gremminger, M.P.P., and others

January 02, 2026

https://www.primetherapeutics.com/w/help-net-security-healthcare-security-is-broken-because-its-systems-can-t-talk-to-each-other https://www.helpnetsecurity.com/2025/11/13/cameron-kracke-prime-therapecutics-healthcare-security-ecosystem/

Help Net Security: Healthcare security is broken because its systems can’t talk to each other

November 13, 2025

Showing 1 to 6 of 132

Categories

PA Research & Publications

https://www.primetherapeutics.com/w/quarterly-drug-pipeline-january-2026 /quarterly-drug-pipeline-january-2026

Quarterly Drug Pipeline: January 2026

January 27, 2026

https://www.primetherapeutics.com/w/quarterly-drug-approvals-january-2026 /quarterly-drug-approvals-january-2026

Quarterly Drug Approvals: January 2026

January 26, 2026

https://www.primetherapeutics.com/w/trending-topics-drug-approvals-january-2026 /trending-topics-drug-approvals-january-2026

Cell & Gene Pipeline Outlook: January 2026

January 21, 2026

https://www.primetherapeutics.com/w/expert-clinical-network-insights-january-2026 /expert-clinical-network-insights-january-2026

Expert Clinical Network Insights: January 2026

January 20, 2026

https://www.primetherapeutics.com/w/fda-decisions-expected-february-2026-1 /fda-decisions-expected-february-2026

FDA Decisions Expected: February 2026

January 15, 2026

Showing 1 to 6 of 199

Login Portals

Members and Consumers
Clients and Health Plans
Pharmacy + Provider Resources

Compliance / Legal

Privacy Policy
Notice of Privacy Practices
Terms of Use
Nondiscrimination + Languages
Subrogation

Company

About us
Careers
News
Media

About us

Corporate social responsibility

Solutions overview

Modern technology

Drug access

Clinical solutions

Condition management

Specialty drug management

Government solutions

Single-state programs

Watch

Listen

Home Delivery

Specialty Pharmacy

Navigate to

Back

Back

Back

Back

Explore what's trending at Prime

What’s next for cell and gene therapies

What’s next for cell and gene therapies

Quarterly Drug Pipeline: January 2026

Quarterly Drug Approvals: January 2026

The Latest

Prime Therapeutics appoints public affairs veteran Katie Payne as chief external affairs officer

Prime Therapeutics supports FDA’s updated biosimilar recommendations

Prime Therapeutics to present latest managed care pharmacy insights at AMCP Nexus 2025

Prime Therapeutics Scales Judi® Platform Implementations with Support from PwC

What's driving medical benefit spend? Prime Therapeutics trend report shares new clues

Prime Therapeutics’ leading research shows only 1 in 12 remain on a GLP-1 drug for obesity at three years

Payers play an evolving role in small cell lung cancer treatment

Inflammatory bowel disease at the crossroads of medical and pharmacy

End-of-year outlook: What’s next for drug approvals, pipeline, and innovation

Integrated oncology insights: Navigating the medical and pharmacy claims landscape

How to safely dispose of medications on National Drug Take Back Day

15 years of insight: Prime’s Medical Pharmacy Trend Report — A must-read for payers

What’s next for cell and gene therapies

Prime Careers Spotlight: January 2026

Prime’s creative and brand work receives industry recognition

Oncology pharmacists are essential in precision medicine, says Prime Therapeutics expert

Prime Therapeutics supports nonprofit’s efforts to empower people with disabilities to live life to the fullest

Prime Therapeutics information technology team earns top industry honors

Prime presents at 73rd annual Roy A. Bowers Pharmaceutical Conference on Nov. 11

Prime presents at HLTH USA conference on Oct. 20

Prime presents 2025 Medical Pharmacy Trend Report webcast on Oct. 13

Prime expert presents at “The Most Favored Nation Mandate” webinar on Sept. 10

Prime presents at National Association of Specialty Pharmacy (NASP) annual meeting from Sept. 14–17

Prime presents at ISG Digital Business Summit on Nov. 14

Managed Healthcare Executive: Why Timing, Access and Interpretation Matter in Oncology Biomarker Testing

Forbes: Causes And Implications Of Discontinuing GLP-1 Weight Loss Drugs

Managed Healthcare Executive: Predictions for 2026 from Marci Chodroff, M.D., Jeffrey Casberg, RPh, M.S., and others

Harper's Bazaar Arabia: Weight Loss Wonder Drugs: Are We Now Seeing Their Wider Impact?

Managed Healthcare Executive: Predictions for 2026 from Margaret A. Murray, M.P.A., Eric Hunter, MBA, Shawn Gremminger, M.P.P., and others

Help Net Security: Healthcare security is broken because its systems can’t talk to each other

Quarterly Drug Pipeline: January 2026

Quarterly Drug Approvals: January 2026

Trending Topics & Drug Approvals: January 2026

Cell & Gene Pipeline Outlook: January 2026

Expert Clinical Network Insights: January 2026

FDA Decisions Expected: February 2026

Login Portals

Compliance / Legal

Company